ArticleFrontiers in oncology2023

HiRAND: A novel GCN semi-supervised deep learning-based framework for classification and feature selection in drug research and development.

Yue Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.